miR-155 Modifies Inflammation, Endothelial Activation and Blood-Brain Barrier Dysfunction in Cerebral Malaria

AbstractmiR-155 has been shown to participate in host response to infection and neuroinflammation via negative regulation of blood-brain barrier (BBB) integrity and T cell function. We hypothesized that miR-155 may contribute to the pathogenesis of cerebral malaria (CM). To test this hypothesis, we used a genetic approach to modulate miR-155 expression in an experimental model of cerebral malaria (ECM). In addition, an engineered endothelialized microvessel system and serum samples from Ugandan children with CM were used to examine anti-miR-155 as a potential adjunctive therapeutic for severe malaria. Despite higher parasitemia, survival was significantly improved in miR-155−/− mice versus wild-type littermate mice in ECM. Improved survival was associated with preservation of BBB integrity and reduced endothelial activation, despite increased levels of proinflammatory cytokines. Pretreatment with antagomir-155 reduced vascular leak induced by human CM sera in an ex vivo endothelial microvessel model. These data provide evidence supporting a mechanistic role for miR-155 in host response to malaria via regulation of endothelial activation, microvascular leak and BBB dysfunction in CM.

[1]  Ashutosh Kumar Singh,et al.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.

[2]  O. Uthman Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. , 2016, Lancet.

[3]  B. Baradaran,et al.  BACH1, the master regulator gene: A novel candidate target for cancer therapy. , 2016, Gene.

[4]  Chris C. Miller,et al.  Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial , 2015, Malaria Journal.

[5]  Ryan M. O’Connell,et al.  Exosome-delivered microRNAs modulate the inflammatory response to endotoxin , 2015, Nature Communications.

[6]  Chen-feng Qi,et al.  Inhibiting the Mammalian Target of Rapamycin Blocks the Development of Experimental Cerebral Malaria , 2015, mBio.

[7]  M. Cybulsky,et al.  Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs. , 2015, Blood.

[8]  Colleen A. Hammond,et al.  Brain swelling and death in children with cerebral malaria. , 2015, The New England journal of medicine.

[9]  C. Poh,et al.  Pathogenic CD8+ T cells in experimental cerebral malaria , 2015, Seminars in Immunopathology.

[10]  J. Fish,et al.  Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation , 2014, Front. Genet..

[11]  Y. Mo,et al.  Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer , 2014, Molecular Cancer.

[12]  C. Poh,et al.  Damage to the Blood-Brain Barrier during Experimental Cerebral Malaria Results from Synergistic Effects of CD8+ T Cells with Different Specificities , 2014, Infection and Immunity.

[13]  Y. Lévy,et al.  Role of miR‐155 in the regulation of lymphocyte immune function and disease , 2014, Immunology.

[14]  Michael S. Behnke,et al.  miR-146a and miR-155 delineate a MicroRNA fingerprint associated with Toxoplasma persistence in the host brain. , 2014, Cell reports.

[15]  B. Sharrack,et al.  MicroRNA‐155 negatively affects blood–brain barrier function during neuroinflammation , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  J. Sled,et al.  PPARγ Agonists Improve Survival and Neurocognitive Outcomes in Experimental Cerebral Malaria and Induce Neuroprotective Pathways in Human Malaria , 2014, PLoS pathogens.

[17]  A. Díez,et al.  Glutathione peroxidase contributes with heme oxygenase-1 to redox balance in mouse brain during the course of cerebral malaria. , 2013, Biochimica et biophysica acta.

[18]  K. Mark Ansel,et al.  MicroRNA-mediated regulation of T helper cell differentiation and plasticity , 2013, Nature Reviews Immunology.

[19]  M. Cybulsky,et al.  MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways , 2013, EMBO molecular medicine.

[20]  F. Ginhoux,et al.  Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection , 2013, Nature Medicine.

[21]  H. Moch,et al.  Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice , 2013, EMBO molecular medicine.

[22]  E. Wherry,et al.  MicroRNA-155 controls CD8+ T cell responses by regulating interferon signaling , 2013, Nature Immunology.

[23]  W. Liles,et al.  Biomarkers of endothelial activation/dysfunction in infectious diseases , 2013, Virulence.

[24]  X. Su,et al.  Malaria biology and disease pathogenesis: insights for new treatments , 2013, Nature Medicine.

[25]  Ying Zheng,et al.  In vitro microvessels for the study of angiogenesis and thrombosis , 2012, Proceedings of the National Academy of Sciences.

[26]  Scott M. Williams,et al.  HMOX1 Gene Promoter Alleles and High HO-1 Levels Are Associated with Severe Malaria in Gambian Children , 2012, PLoS pathogens.

[27]  M. Molyneux,et al.  Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: A retrospective case–control study* , 2012, Critical care medicine.

[28]  A. Tijsen,et al.  Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? , 2012, Circulation research.

[29]  S. Ylä-Herttuala,et al.  Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells. , 2011, Free radical biology & medicine.

[30]  Chris C. Miller,et al.  Inhaled Nitric Oxide Reduces Endothelial Activation and Parasite Accumulation in the Brain, and Enhances Survival in Experimental Cerebral Malaria , 2011, PloS one.

[31]  A. Zarbock,et al.  Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo , 2011, The Journal of experimental medicine.

[32]  K. Kain,et al.  Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics , 2011, Current opinion in hematology.

[33]  W. Liles,et al.  Endothelial activation, dysfunction and permeability during severe infections , 2011, Current opinion in hematology.

[34]  D. Streiner,et al.  Combinations of Host Biomarkers Predict Mortality among Ugandan Children with Severe Malaria: A Retrospective Case-Control Study , 2011, PloS one.

[35]  M. Molyneux,et al.  Endothelium-Based Biomarkers Are Associated with Cerebral Malaria in Malawian Children: A Retrospective Case-Control Study , 2010, PloS one.

[36]  Kamolrat Silamut,et al.  Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial , 2010, The Lancet.

[37]  K. Kain,et al.  Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children , 2009, PloS one.

[38]  R. Price,et al.  Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria , 2008, Proceedings of the National Academy of Sciences.

[39]  Samir N. Patel,et al.  C5 deficiency and C5a or C5aR blockade protects against cerebral malaria , 2008, The Journal of experimental medicine.

[40]  K. Kain,et al.  Pyruvate kinase deficiency and malaria. , 2008, The New England journal of medicine.

[41]  M. Mota,et al.  Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria , 2007, Nature Medicine.

[42]  Anton J. Enright,et al.  Requirement of bic/microRNA-155 for Normal Immune Function , 2007, Science.

[43]  G. Hutvagner,et al.  Principles and effects of microRNA-mediated post-transcriptional gene regulation , 2006, Oncogene.

[44]  D. Christiani,et al.  Leaking Capillaries and White Lung in Sepsis—Is Angiopoietin 2 the Culprit? Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans. PLoS Medicine 3: e46, 2006 , 2006 .

[45]  H. Augustin,et al.  Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation , 2006, Nature Medicine.

[46]  D. Christiani,et al.  Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans , 2006, PLoS medicine.

[47]  N. Rajewsky,et al.  Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.

[48]  Arjen Dondorp,et al.  Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial , 2005, The Lancet.

[49]  P. Gros,et al.  Pyruvate kinase deficiency in mice protects against malaria , 2003, Nature Genetics.

[50]  M. Marron,et al.  The Antiinflammatory Endothelial Tyrosine Kinase Tie2 Interacts With a Novel Nuclear Factor-&kgr;B Inhibitor ABIN-2 , 2003, Circulation research.

[51]  S. Shibahara,et al.  Bach1 Functions as a Hypoxia-inducible Repressor for the Heme Oxygenase-1 Gene in Human Cells* , 2003, The Journal of Biological Chemistry.

[52]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[53]  J. York,et al.  The Endothelial Receptor Tyrosine Kinase Tie1 Activates Phosphatidylinositol 3-Kinase and Akt To Inhibit Apoptosis , 2002, Molecular and Cellular Biology.

[54]  Hyung Jin Kim,et al.  Vascular Endothelial Growth Factor Expression of Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 (VCAM-1), and E-selectin through Nuclear Factor-κB Activation in Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[55]  T. Taylor,et al.  Blood-brain barrier function in cerebral malaria in Malawian children. , 2001, The American journal of tropical medicine and hygiene.

[56]  Davis,et al.  An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. , 1994, The American journal of pathology.

[57]  M. Molyneux,et al.  Tumor necrosis factor and disease severity in children with falciparum malaria. , 1989, The New England journal of medicine.

[58]  K. Kain,et al.  S 1 P Is Associated with Protection in Human and Experimental Cerebral Malaria , 2011 .

[59]  K. Kain,et al.  S1P Is Associated with Protection in Human and Experimental Cerebral Malaria , 2011, Molecular medicine.

[60]  J. Gutkind,et al.  Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. , 2008, Developmental cell.

[61]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .